New York, NY – According to filings with the U.S. Securities and Exchange Commission, Nectar Life Sciences is raising $24,259,999.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ken Chahine played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Nectar Life Sciences
The most personalized, accessible, and comprehensive allergy care platform.

To learn more about Nectar Life Sciences, visit http://www.mynectar.com/

Contact:
Ken Chahine, Chief Executive Officer
888-851-3336

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved